Modelling Metabolic Shifts during Cardiomyocyte Differentiation, Iron Deficiency and Transferrin Rescue Using Human
Benjamin B Johnson1, Johannes Reinhold1, Terri L Holmes1
1Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norwich NR4 7UQ, UK.
Iron deficiency impairs heart cell metabolism, shifting energy reliance to glycolysis. While iron replenishment partially restores metabolic function, some pathways remain affected, suggesting new therapeutic targets for cardiovascular diseases.
Area of Science:
- Cardiovascular Biology
- Cellular Metabolism
- Iron Metabolism
Background:
- Cardiomyocytes have specialized metabolic needs for high energy demand.
- Heart metabolism matures during development, shifting from glycolysis to fatty acid oxidation.
- Iron deficiency (ID) causes cellular metabolism disruptions, but specific alterations are unclear.
Purpose of the Study:
- To investigate metabolic substrate utilization changes in cardiomyocytes during iron deficiency.
- To assess the impact of transferrin rescue on metabolism in iron-deficient cardiomyocytes.
- To identify potential biomarkers and therapeutic targets for cardiovascular diseases related to iron deficiency.
Main Methods:
- Utilized human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CM).
- Induced iron deficiency and performed transferrin rescue experiments.
- Analyzed major metabolic substrate utilization, including fatty acid, glycolysis, and TCA cycle pathways.
Main Results:
- Fatty acid metabolism showed the greatest increase during hiPSC-CM differentiation.
- Iron deficiency led to increased reliance on glycolysis and impaired TCA cycle, amino acid, and fatty acid substrates.
- Transferrin rescue partially improved TCA cycle metabolism, but amino acid and fatty acid metabolism remained perturbed.
Conclusions:
- Iron deficiency significantly alters cardiomyocyte substrate metabolism, favoring glycolysis.
- Partial iron replenishment can reverse some adverse metabolic changes.
- Metabolic alterations in iron deficiency present potential targets for cardiovascular disease therapies.
More Related Videos
13:18Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
13:13High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
